Live from the NIH registry
Studies recruiting near Palm Bay right now
Top 25 of 60 recruiting studies, sorted by proximity — each links to its official registry page
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Cancer Care Centers of Brevard, Inc — Palm Bay, Florida (6.5 mi)
· Sponsor: Relay Therapeutics, Inc.
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12079 — Melbourne, Florida (8.9 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive Disorder
Phase 3
Interventional 850 participants sought
Neurocrine Clinical Site — Palm Bay, Florida (6.5 mi)
· Sponsor: Neurocrine Biosciences
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
Chronic Total Occlusion of Artery of the Extremities
N/A
Interventional 65 participants sought
Vascular & Embolization Specialists — Cocoa, Florida (29.7 mi)
· Sponsor: Versono Medical Ltd
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Viera, Florida (20.2 mi)
· Sponsor: Akero Therapeutics, Inc
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Cancer Care Centers of Brevard — Rockledge, Florida (27.1 mi)
· Sponsor: Agendia
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 1,000 participants sought
Local Institution - 1131 — Viera, Florida (20.2 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Phase 3
Interventional 4,220 participants sought
Cancer Care Centers of Brevard (CCCB) - Palm Bay — Palm Bay, Florida (6.5 mi)
· Sponsor: Stemline Therapeutics, Inc.
MYLUNG Consortium Part 3: Observational Study
Carcinoma, Non-Small-Cell Lung
N/A
Observational 7,500 participants sought
Cancer Care Centers of Brevard, Inc. — Palm Bay, Florida (6.5 mi)
· Sponsor: US Oncology Research
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
Merritt Island Medical Research, LLC — Merritt Island, Florida (27.4 mi)
· Sponsor: Eli Lilly and Company
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Alzheimer Disease, Dementia
Phase 3
Interventional 550 participants sought
Merritt Island Medical Research, LLC — Merritt Island, Florida (27.4 mi)
· Sponsor: Eli Lilly and Company
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Urothelial Carcinoma
Phase 2
Interventional 372 participants sought
Florida Cancer Specialists — Vero Beach, Florida (27.6 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Early Alzheimer's Disease
Phase 2
Interventional 340 participants sought
ClinCloud LLC ( Site 1039) — Melbourne, Florida (8.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Merritt Island Medical Research, LLC — Merritt Island, Florida (27.4 mi)
· Sponsor: Bristol-Myers Squibb
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
Mild Cognitive Impairment, Alzheimer's Disease
N/A
Observational 1,200 participants sought
Clincloud — Melbourne, Florida (8.9 mi)
· Sponsor: GAP Innovations, PBC
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Cancer Care Centers of Brevard — Palm Bay, Florida (6.5 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Atherosclerosis, Cardiovascular Diseases
Phase 3
Interventional 252 participants sought
Merritt Island Medical Research, LLC — Merritt Island, Florida (27.4 mi)
· Sponsor: Eli Lilly and Company
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Breast Cancer
Phase 3
Interventional 625 participants sought
Research Site — Palm Bay, Florida (6.5 mi)
· Sponsor: AstraZeneca
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
Phase 3
Interventional 5,000 participants sought
Research Site — Melbourne, Florida (8.9 mi)
· Sponsor: AstraZeneca
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Proteinuric Kidney Disease
Phase 2
Interventional 56 participants sought
Research Site — Melbourne, Florida (8.9 mi)
· Sponsor: Maze Therapeutics
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Neovascular (Wet) Age-Related Macular Degeneration
Phase 1, Phase 2
Interventional 215 participants sought
Florida Eye Associates — Melbourne, Florida (8.9 mi)
· Sponsor: 4D Molecular Therapeutics
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Palm Bay, Florida (6.5 mi)
· Sponsor: AstraZeneca
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 2, Phase 3
Interventional 650 participants sought
Site #0136 — Palm Bay, Florida (6.5 mi)
· Sponsor: Bicara Therapeutics
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Viera, Florida (20.2 mi)
· Sponsor: 89bio, Inc.
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Stereotypical Prolonged Seizures
Phase 3
Interventional 350 participants sought
Ep0162 50703 — Rockledge, Florida (27.1 mi)
· Sponsor: UCB Biopharma SRL